gienists Worldwide. Dr. Breysse received his MHS in occupational safety and health and his PhD in environmental health engineering from the Johns Hopkins University.
Scott W. Burchiel is a professor of pharmacology and toxicology in the College of Pharmacy of the University of New Mexico Health Sciences Center. He is associate dean for research at the college, director of the New Mexico Center for Environmental Health Sciences, and a member of the University of New Mexico Cancer Research and Treatment Center. His research interests are in immunotoxicology, cancer research, pharmacogenomics, and biotechnology. His laboratory examines the effects of drugs and environmental agents on signaling pathways that control lymphocyte activation and apoptosis, proto-oncogene activation, and mechanisms of signaling in human mammary epithelial cells. Dr. Burchiel was a member of the National Research Council Committee on Assessing Human Health Risks of Trichloroethylene. He received his PhD in pharmacology from the University of California, San Francisco.
Lung Chi Chen is an associate professor in the Department of Environmental Medicine of the New York University (NYU) School of Medicine. He is also director of the Inhalation Facility for the National Institute of Environmental Health Sciences Center of Excellence. His research interests are in inhalation toxicology and exposure-response relationships. His recent research has focused on nanoparticle toxicity and functional use, the role of health disparity in airpollution-induced cardiopulmonary diseases, and gene-environment interactions in environmentally induced diseases. Dr. Chen is vice president-elect of the Inhalation Specialty Section of the Society of Toxicology. He received his MS and PhD in environmental health science from NYU.
David Díaz-Sánchez is chief of the Clinical Research Branch of the U.S. Environmental Protection Agency (EPA). Before joining EPA in 2007, he was an associate professor in the Department of Medicine of the University of California, Los Angeles. His research interests are in the use of human and animal models to understand the ability of environmental agents to affect immune responses, particularly agents that modulate allergic and asthmatic responses. His recent work has focused on how diesel-exhaust particles exacerbate allergy and asthma, the role of phase II enzymes in conferring susceptibility to pollutants, and the role of oxidative stress in susceptibility to particulate matter and in the potency of particles in promoting airway inflammation. Dr. Díaz-Sánchez is a member of the National Ambient Air Monitoring Strategy Subcommittee of EPA’s Clean Air Science Advisory Committee. He received his PhD from Guy’s Hospital in London.
David G. Hoel is Distinguished University Professor in the Department of Biostatistics, Bioinformatics, and Epidemiology of the Medical University of South Carolina. He also holds an appointment as clinical professor in the Department